Nucleocytoplasmic trafficking is an essential and responsive cellular mechanism that directly affects cell growth and proliferation, and its potential to address metabolic challenge is incompletely defined. Ceramide is an antiproliferative sphingolipid found within vascular smooth muscle cells in atherosclerotic plaques, but its mechanism of action remains unclear. The hypothesis that ceramide inhibits cell growth through nuclear transport regulation was tested. In smooth muscle cells, exogenously supplemented ceramide inhibited classical nuclear protein import that involved the activation of cytosolic p38 mitogen-activated protein kinase (MAPK). After application of SB 202190, a specific and potent pharmacological antagonist of p38 MAPK, sphingolipid impingement on nuclear transport was corrected. Distribution pattern assessments of two essential nuclear transport proteins, importin-a and Cellular Apoptosis Susceptibility, revealed ceramide-mediated relocalization that was reversed upon the addition of SB 202190. Furthermore, cell counts, nuclear cyclin A, and proliferating cell nuclear antigen expression, markers of cellular proliferation, were diminished after ceramide treatment and effectively rescued by the addition of inhibitor. Together, these data demonstrate, for the first time, the sphingolipid regulation of nuclear import that defines and expands the adaptive capacity of the nucleocytoplasmic transport machinery. Synthesized in the sphingolipid pathway from serine and palmitoyl-CoA (1) or generated by sphingomyelinase activity (2), ceramide is an important second messenger that primarily stimulates apoptosis and growth arrest (3, 4). Reported to induce a significant antiproliferative effect in vascular smooth muscle cells (VSMCs) (5, 6), the mechanism whereby ceramide affects cellular proliferation has not been fully elucidated.Proliferation and growth are regulated by nuclear transport (7,8). An essential eukaryotic process, nucleocytoplasmic transport, describes the regulated movement of molecules between nuclear and cytoplasmic compartments (9, 10), defined by cytosolic (11, 12) and membrane-bound (13-15) phases, that characterize the distribution of the nuclear transport machinery. Classical nuclear import involves proteins that bear a monopartite or bipartite polybasic amino acid sequence [nuclear localization signal (NLS)] (16). Transport is initiated upon energy-independent NLS recognition by a heterodimeric NLS receptor (17, 18) composed of an a subunit (importin-a), which recognizes the NLS (19), and a b subunit (20) (importin-b), which mediates nuclear pore complex docking at the nuclear envelope (21-23). Translocation of the NLS-receptor assembly through the nuclear pore complex is an energydependent process (24-26) controlled by a RanGTP/GDP cycle (27-29). Importin-a is returned to the cytosol by CAS (for Cellular Apoptosis Susceptibility), a nuclear export protein specific for the a subunit (30). Importin-b is recycled independently of the a subunit, and the NLS bearing protein c...